Literature DB >> 3063503

Interrelationship of hypertension, plasma lipids and atherosclerosis.

J M Krzesinski1, P G Carlier, G L Rorive.   

Abstract

The relationship between hypertension and atherosclerosis has been illustrated by epidemiological, clinical and experimental observations. Typical atherosclerotic lesions develop in arterial wall when hypercholesterolaemia is present. Hypertension aggravates these lesions by causing vascular structural changes. In clinical studies, however, the correction of high blood pressure does not decrease the incidence of coronary heart disease. Several hypotheses have been formulated to account for this observation: one is that reversibility of the structural vascular changes induced by hypertension is not complete when the blood pressure is lowered; another is that antihypertensive drugs have a deleterious effect on the vascular wall.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3063503     DOI: 10.2165/00003495-198800362-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  61 in total

1.  THE CELLULAR PATHOLOGY OF EXPERIMENTAL HYPERTENSION. I. HYPERPLASTIC ARTERIOLARSCLEROSIS.

Authors:  D SPIRO; R G LATTES; J WIENER
Journal:  Am J Pathol       Date:  1965-07       Impact factor: 4.307

2.  The relationship between experimental hypertension and cholesterol-induced atheroma in rabbits.

Authors:  B BRONTE-STEWART; R H HEPTINSTALL
Journal:  J Pathol Bacteriol       Date:  1954-10

3.  Lipoprotein-acid mucopolysaccharide complexes of human atherosclerotic lesions.

Authors:  S R Srinivasan; B Radhakrishnamurthy; P S Pargaonkar; G S Berenson; P Dolan
Journal:  Biochim Biophys Acta       Date:  1975-04-18

Review 4.  Mesenchymal response of the blood vessel wall. A potential avenue for understanding and treating atherosclerosis.

Authors:  H Wolinsky
Journal:  Circ Res       Date:  1973-05       Impact factor: 17.367

5.  Renin as a risk factor for atherogenesis. Part 3. Effects of hypercholesterolemia, hyporeninemia and one-kidney-one clip hypertension in the rabbit.

Authors:  M L Overturf; H D Sybers; R E Druilhet; W M Kirkendall
Journal:  Atherosclerosis       Date:  1982-04       Impact factor: 5.162

6.  Alterations of energy metabolism in the spontaneously hypertensive rat: a 31P nuclear magnetic resonance study.

Authors:  P G Carlier; M D Jacobstein; M A Portman; F Fouad; R C Tarazi; T A Gerken
Journal:  J Hypertens Suppl       Date:  1986-12

7.  Kinetics of proliferation of rat aortic smooth muscle cells in Goldblatt one-kidney, one-clip hypertension.

Authors:  P G Carlier; G Rorive; H Barbason
Journal:  Clin Sci (Lond)       Date:  1983-10       Impact factor: 6.124

8.  The effect of thrombocytopenia on experimental arteriosclerotic lesion formation in rabbits. Smooth muscle cell proliferation and re-endothelialization.

Authors:  R J Friedman; M B Stemerman; B Wenz; S Moore; J Gauldie; M Gent; M L Tiell; H Spaet
Journal:  J Clin Invest       Date:  1977-11       Impact factor: 14.808

9.  Effects of long-term verapamil treatment on blood pressure, cardiac hypertrophy and collagen metabolism in spontaneously hypertensive rats.

Authors:  H J Ruskoaho; E R Savolainen
Journal:  Cardiovasc Res       Date:  1985-06       Impact factor: 10.787

10.  Verapamil enhances receptor-mediated endocytosis of low density lipoproteins by aortic cells in culture.

Authors:  O Stein; E Leitersdorf; Y Stein
Journal:  Arteriosclerosis       Date:  1985 Jan-Feb
View more
  2 in total

1.  Effects of dicentrine on haemodynamic, plasma lipid, lipoprotein level and vascular reactivity in hyperlipidaemic rats.

Authors:  S M Yu; Y F Kang; C C Chen; C M Teng
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

2.  Diet-induced swine model with obesity/leptin resistance for the study of metabolic syndrome and type 2 diabetes.

Authors:  L Torres-Rovira; S Astiz; A Caro; C Lopez-Bote; C Ovilo; P Pallares; M L Perez-Solana; R Sanchez-Sanchez; A Gonzalez-Bulnes
Journal:  ScientificWorldJournal       Date:  2012-05-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.